Industri

How Correctional Administrators Can Prepare Themselves,...

One of the many issues that correctional administrators are facing today is the ...

Panel Discussion: Are we measuring FR&D success the rig...

FDD Conclave 2026 | 6th August 2026 | Ahmedabad Connect The post Panel Discussi...

Dr Abhijit Gothoskar, Technical Expert, Sigachi Industries

FDD Conclave 2026 | 6th August 2026 | Ahmedabad Connect The post Dr Abhijit Got...

Dr Ajay Jaysingh Khopade, Site Head R&D, VP and Head-Fo...

FDD Conclave 2026 | 6th August 2026 | Ahmedabad Connect The post Dr Ajay Jaysin...

Ms Ritu Laddha, Sr VP & Cluster Head, Zydus Lifesciences

FDD Conclave 2026 | 6th August 2026 | Ahmedabad Connect The post Ms Ritu Laddha...

Panel Discussion: AI, talent and technology: The new FR...

FDD Conclave 2026 | 6th August 2026 | Ahmedabad Connect The post Panel Discuss...

Dr Richa Dayaramani, Scientist Grade F, NIPER Ahmedabad

FDD Conclave 2026 | 6th August 2026 | Ahmedabad Connect The post Dr Richa Daya...

Panel Discussion: Ahmedabad’s innovation edge: Where sc...

FDD Conclave 2026 | 6th August 2026 | Ahmedabad Connect The post Panel Discuss...

BioE3 at 2: From policy push to industry scale

Podcast with Dr. Rahul Warke, Ph.D., Director, Research and Development (Microb...

Teva Pharmaceuticals to acquire BioXcel assets for up t...

The agreement arises as part of BioXcel Therapeutics’ voluntary Chapter 11 proce...

AusperBio raises $120m to progress hepatitis B therapies

The round was led by an undisclosed strategic investor. New investor RA Capital ...

Lannett launches generic Advair Diskus in US

Aurobindo Pharma USA subsidiary introduces fluticasone propionate and salmetero...

MetaG1 launches scientific discussion platform for phar...

Bengaluru-based initiative aims to preserve expert discussions on evidence, met...

Zydus reports positive Phase II(b) EVIDENCES-X results ...

Global trial met its primary endpoint of MASH resolution without worsening of f...

Bombay HC directs Maharashtra FDA to withdraw Cipla lic...

Court questions FDA’s handling of proceedings and directs regulator to issue fr...

Maharashtra FDA cancels Cipla C&F drug sale licences in...

The action follows inspections in June 2026 involving Reactin Plus Tablets, a S...